Cialis Generic Le Weekend Pill Generic Cialis ® Medical Info Information: Canada Online prescription::Canada prescriptions:: Generic Cialis® weekend pill Drugs- Medicine Viagra Apidex Pharmacy

SEXUAL HEALTH
	GENERIC CIALIS® Regalis
	VIAGRA® Sildenafil C

cialis generic

Regalis
Generic Cialis®

4 Pills 20mg
(blister package)

$30

Compare this price to Brand Name Cialis® = $94
CIALIS GENERIC

Generic Cialis®

Welcome to xlpharmacy.com your online solution for quality generic and brand name medications at affordable prices!

We have some great medications to offer you and will be adding many more in the coming weeks.

90% off CIALIS GENERIC RETAIL PRICES !!!

Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses
by
Brock GB, McMahon CG, Chen KK, Costigan T,
Shen W, Watkins V, Anglin G, Whitaker S.
Department of Surgery, Division of Urology,
Faculty of Medicine and Dentistry,
University of Western Ontario, London, Canada.
J Urol 2002 Oct;168(4 Pt 1):1332-6

ABSTRACT CIALIS GENERIC
PURPOSE: We conducted integrated analyses of the efficacy and safety of tadalafil, a potent, selective phosphodiesterase 5 inhibitor, for the treatment of erectile dysfunction. MATERIALS AND METHODS: A total of 1,112 men with a mean age of 59 years (range 22 to 82) and mild to severe erectile dysfunction of various etiologies were randomized to placebo or tadalafil, taken as needed without food or alcohol restrictions, at fixed daily doses of 2.5 mg., 5 mg., 10 mg., or 20 mg. in 5 randomized, double-blind, placebo controlled trials lasting 12 weeks. The 3 co-primary outcomes were changes from baseline in the erectile function domain of the International Index of Erectile Function and the proportion of "yes" responses to questions 2 and 3 of the Sexual Encounter Profile. Additional efficacy instruments included a Global Assessment Question. RESULTS: Compared with placebo, tadalafil significantly enhanced all efficacy outcomes. Patients receiving 20 mg. tadalafil experienced a significant mean improvement of 7.9 in International Index of Erectile Function erectile function domain score from baseline (p <0.001 versus placebo), 75% of intercourse attempts (Sexual Encounter Profile question 3, a secondary efficacy outcome) were successfully completed (p <0.001 versus placebo) and 81% reported improved erections at end point compared with 35% in the control group (p <0.001). Tadalafil was consistently efficacious across disease severities and etiologies, as well as in patients of all ages. Tadalafil was well tolerated, and headache and dyspepsia were the most frequent adverse events.

CONCLUSIONS: Tadalafil was effective and well tolerated in this patient population.

CIALIS GENERIC

On-demand IC351 (Cialistrade mark) enhances erectile function in patients with erectile dysfunction.
Source: Int J Impot Res 2001 Feb; 13(1): 2-9

Padma-Nathan H, McMurray JG, Pullman WE, Whitaker JS, Saoud JB, Ferguson KM, Rosen RC.
Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

IC351 (Cialistrade mark) is a selective inhibitor of PDE5. The efficacy and safety of on-demand dosing of IC351 in men with erectile dysfunction was assessed in a multicenter, double-blind, placebo-controlled study. One hundred seventy-nine men (mean age: 56 y) were randomized to receive placebo or IC351 at doses of 2, 5, 10 or 25 mg, taken on demand over a 3-week period. The primary endpoints were change from baseline in responses to Questions 3 (Q3) and 4 (Q4) of the International Index of Erectile Function (IIEF). IC351 significantly improved IIEF Q3 scores at all doses vs placebo (P

The most common adverse events were headache and dyspepsia. The conclusion of this study was that on-demand IC351 at doses up to 25 mg was well tolerated and significantly improved erectile function.

Cialis Generic or Generic Cialis Research

Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial
by
Porst H.
Porst H, Padma-Nathan H, Giuliano F,
Anglin G, Varanese L, Rosen R.
Private Urological Practice, Hamburg, Germany.
Urology. 2003 Jul;62(1):121-5; discussion 125-6.

ABSTRACT OBJECTIVES: To examine the therapeutic effects of tadalafil on erectile dysfunction (ED) at 24 and 36 hours after dosing.

METHODS: A multicenter, randomized, double-blind, placebo-controlled, parallel-group study of 348 men (mean age 57 years) with ED was conducted in Europe and the United States. Patients were stratified by baseline severity of ED using the Erectile Function domain score of the International Index of Erectile Function and then randomly allocated within the severity group to receive tadalafil 20 mg (n = 175) or placebo (n = 173). Subsequently, participants were randomly assigned to two 4-week treatment intervals, during which they were requested to attempt sexual intercourse approximately 24 or 36 hours after tadalafil or placebo dosing. The primary outcome measure was the proportion of successful sexual intercourse attempts (completed to ejaculation) according to patient self-report using the Sexual Encounter Profile diary. RESULTS: Of the 348 patients, 327 (94%) completed the trial (163 of 175 in the tadalafil group and 164 of 173 in the placebo group). Thirty-six hours after tadalafil dosing, 59.2% of intercourse attempts were successful versus 28.3% in the placebo group (P <0.001). The proportion of successful intercourse attempts at approximately 24 hours after treatment was also significantly greater with tadalafil (52.9%) than with placebo (29.1%; P <0.001). Tadalafil was well tolerated. The incidences of four treatment-emergent adverse events were significantly greater in the tadalafil group than in the placebo group (all P <0.05): headache, flushing, dyspepsia, and myalgia. CONCLUSIONS: Tadalafil 20 mg is an effective and well-tolerated treatment for ED that has a period of responsiveness of up to 36 hours.

SEODoctor.com- Search Engine Positioning Tool